Cargando…
The Use of COVID-19 Vaccines in Patients with SLE
PURPOSE OF REVIEW: Three COVID-19 vaccines obtained emergency authorization from the Food and Drug Administration (FDA) and are widely used in the USA. Unfortunately, there is a paucity of evidence on the safety and efficacy of these vaccines in patients with autoimmune inflammatory rheumatic diseas...
Autores principales: | Tang, Wei, Gartshteyn, Yevgeniya, Ricker, Edd, Inzerillo, Sean, Murray, Shane, Khalili, Leila, Askanase, Anca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586600/ https://www.ncbi.nlm.nih.gov/pubmed/34767100 http://dx.doi.org/10.1007/s11926-021-01046-2 |
Ejemplares similares
-
Epigenetics in SLE
por: Hedrich, Christian Michael
Publicado: (2017) -
A Review of Complement Activation in SLE
por: Weinstein, Arthur, et al.
Publicado: (2021) -
The Representation of Gender and Race/Ethnic Groups in Randomized Clinical Trials of Individuals with Systemic Lupus Erythematosus
por: Falasinnu, Titilola, et al.
Publicado: (2018) -
Cell Senescence in Lupus
por: Gao, Lin, et al.
Publicado: (2019) -
New Attempts to Define and Clarify Lupus
por: Alarcón-Riquelme, Marta E.
Publicado: (2019)